The relevant investigative protocol and/or patient note may be attached to your patient's printed or electronic result.
The range of investigative protocols cover conditions associated with:
Clinical Conditions
Coagulation Tests
| Abbreviation |
IP Title |
| Platelet |
Platelet function analysis |
| Thrombosis |
Risk factors for venous thromboembolism |
| vWF1 |
von Willebrand disease |
Drug Screen Interpretation
| Abbreviation |
IP Title |
| Methadone |
Evaluation of EDDP (methadone metabolite) results |
| THC |
Evaluation of 9-tetrahydrocannabinol (THC) results |
| UDS |
Urine drug screening |
| UDS Amph |
Evaluation of Amphetamine type substance results |
| UDS Benzo |
Evaluation of benzodiazepine results |
| UDS Cocaine |
Evaluation of cocaine results |
| UDS Opiate |
Evaluation of opiate results |
| UDS TLC |
Thin layer chromotography |
Endocrine Tests
| Abbreviation |
IP Title |
| Vitamin B12 |
Investigation of Low Vitamin B12 |
| TSH High |
Evaluation of an elevated serum TSH (> 5.0 mU/L) |
| TSH Low |
Evaluation of a subnormal serum TSH (< 0.3 mU/L) |
General Biochemistry
| Abbreviation |
IP Title |
| Bicarb Low |
Causes of low plasma bicarbonate (bicarbonate < 18) |
| Bicarb High |
Flowchart for assessment of high plasma bicarbonate |
| Calcium High 1 |
Causes of hypercalcaemia (calcium > 2.6) |
| Calcium High 2 |
Evaluation of hypercalcaemia (calcium > 2.6) |
| Calcium Low |
Evaluation of hypocalcaemia (calcium < 2.2) |
| CK High |
Causes of an elevated CK (M > 200 F > 140) |
| Diabetes Mellitus |
Screening for Type 2 Diabetes Mellitus |
| eGFR |
Estimated Glomerular Filtration Rate (eGFR) |
| Globulin High |
Evaluation of hyperglobulinaemia (globulins > 44) |
| Glucose Low |
Evaluation of hypoglycaemia (plasma glucose < 2.8 mmol/L) |
| Haemochromatosis |
Venesection for Haemochromatosis |
| LDI |
Evaluation of Lactate Dehydrogenase Isoenzymes (LDI) |
| Lipid Lowering Drugs |
PBS Criteria for Lipid Lowering Drugs |
| Lipid Lowering Drugs (2) |
PBS Criteria for Lipid Lowering Drugs: High Risk Patients |
| MI Change |
Cardiac enzyme changes during myocardial infarction |
| Mag Low |
Causes of hypomagnesaemia (magnesium < 0.7mmol/L) |
| Metabolic Syndrome |
Metabolic Syndrome - International Diabetes Federation Definition |
| Phos High |
Causes of hyperphosphataemia (phosphate > 1.8) |
| Phos Low |
Causes of hypophosphataemia (mild 0.5~0.65 mmol/L; severe < 0.4 mmol/L)
|
| Polyuria |
Evaluation of polyuria (urine volume > 3L/24hrs) |
| Pot High 1 |
Causes of hyperkalaemia (potassium > 5.0) |
| Pot High 2 |
Evaluation of hyperkalaemia (potassium > 5.0) |
| Pot Low 1 |
Causes of hypokalaemia (potassium < 3.0) |
| Pot Low 2 |
Evaluation of hypokalaemia (potassium < 3.0) |
| Proteinuria |
Screening for Proteinuria and Chronic Kidney Disease |
| Sodium Low |
Causes of hyponatraemia (sodium < 130) Flowchart for Assessment |
| Sodium High |
Causes of hypernatraemia (sodium > 150) |
| Urate High |
Evaluation of hyperuricaemia (M > 0.45 F > 0.40) |
Immunology
Liver Function Tests
Microbiology
| Abbreviation |
IP Title |
| Haematuria |
Causes of isolated microscopic haematuria |
Serology
| Abbreviation |
IP Title |
| HCV |
Hepatitis C virus (HCV) Medicare criteria |
| Helicobacter pylori |
Management of Helicobacter pylori infection |
| Hep A |
Serological events in acute (self-limiting) Hepatitis A infection relative to ALT peak |
| Hep B 1 |
Serological events in acute (self-limiting) Hepatitis B infection relative to ALT peak |
| Hep B 2 |
Hepatitis B immune status |
| HIV |
Useful information at time of diagnosis to assist GPs in delivering diagnosis, understanding legal responsibilities and providing support to the patient. |
| Pertussis |
Treatment of Bordetella pertussis |
| Syphilis |
Treatment of syphilis |
| Q Fever |
Prevaccination Q fever screening |
Warfarin Management
| Abbreviation |
IP Title |
| Warfarin 1 |
Range of International Normalised Ratio (INR) recommended for specific applications of Warfarin therapy |
| Warfarin 2 |
Guidelines to the management of an elevated INR, with or without bleeding |
| Warfarin 3 |
Risk factors for bleeding complications of Warfarin therapy |
Patient Notes
| Abbreviation |
IP Title |
| Occult blood |
Faecal occult blood |
| What is Barmah Forest virus? |
Symptoms, incubation, treatment and prevention of Barmah Forest virus |
| What is blastocystosis? |
Symptoms, infection period, diagnosis, treatment and prevention of blastocystosis |
| What is cryptosporidiosis? |
Symptoms, infection period, spread of infection and treatment of cryptosporidiosis |
| What is giardiasis? |
Symptoms, infection period, spread of infection, diagnosis, treatment and prevention of giardiasis |
| What is listeriosis? |
Symptoms, causes, infection period, diagnosis, treatment and prevention of listeriosis |
| What is parvovirus? |
Causes, infection period, spread of infection, diagnosis, treatment and prevention of parvovirus |
| What is Ross River virus? |
Symptoms, infection period, spread of infection, diagnosis, treatment and prevention of Ross River virus |